Figure 1From: Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families Flow diagram summarizing the strategy for identifying PALB2 c.1592delT mutation carriers in a Northern Finnish 1997–2011 study cohort consisting of high-risk breast cancer family index patients that had tested negative for mutations in BRCA1 / BRCA2 . Back to article page